Facebook
X
LinkedIn
Forward| Title | Credit | Series date |
Member price |
Non-member price |
|---|---|---|---|---|
|
Emerging Health Threats in Infants: Perinatal Hepatitis C 0.75 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and non-members. Emerging Health Threats in Infants: Perinatal Hepatitis C. |
|
02/17/2025 to 01/31/2027 | $0.00 | $0.00 |
|
Hidden in Plain Sight: Uncovering Cytomegalovirus (CMV) for the Pediatric NP 0.75 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and non-members. |
|
02/17/2025 to 01/31/2027 | $0.00 | $0.00 |
|
Human Trafficking: Raising Awareness to Identify Victims in the Clinical Setting Providers must register for a free PedsCE account, and be logged in to watch the webinar and receive the certificate. This course was created in collaboration with NAPNAP Partners for Vulnerable Youth. This continuing education activity is offered free for NAPNAP members and nonmembers. |
|
10/06/2020 to 08/29/2027 | $0.00 | $0.00 |
|
When the Trafficker Is a Family Member: A Case Study 1.5 CE contact hour. This continuing education activity is offered free. This presentation will examine what family-involved sex trafficking entails, including risk factors, clinical indicators, and appropriate responses. Additionally, students will gain insights into a case study about a child in a clinical setting who experienced family-involved sex trafficking and receive preliminary findings from a literature review on this subject. |
|
06/01/2026 to 06/30/2028 | $0.00 | $0.00 |
|
2026 Immunization Update 1.25 NAPNAP Contact Hour of which 1.25 contain pharmacology content. This continuing education activity is offered free for NAPNAP Members. For non-members, this continuing education activity rate is $12.50. A 75-minute panel discussion with pediatric immunization experts will offer a level setting of the past, present, and future status of pediatric immunizations, and focus on science, evidence and advocacy. |
|
05/01/2026 to 04/30/2027 | $0.00 | $12.50 |
|
JPHC CE: Use of Atypical Antipsychotics in Pediatric Populations 1.75 NAPNAP contact hour of which 1.75 contain pharmacology content (Rx). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Atypical antipsychotic medications have served as mainstays in the treatment of pediatric-onset bipolar disorder and schizophrenia and are typically prescribed by psychiatric providers. These medications also have an important role in treating specific behaviors associated with other pediatric diagnoses, including autism spec-trum disorder, disruptive behavior disorders, and tic disorders. Nurse practitioners play an important role in initiating treatment in children who require these drugs and monitoring those who are already prescribed these medications by psychiatric professionals. The pharmacokinetics, pharmacodynamics, and pharmacogenomic implications for aripiprazole, olanzapine, quetiapine, and risperidone are described. This article reviews appropriate approaches to prescribing, monitoring for efficacy and side effects, and considerations when tapering or discontinuing antipsychotic medications. J pediatr Health Care. (2026) 40, 464−474. |
|
05/01/2026 to 06/30/2027 | $0.00 | $10.00 |
|
JPHC CE: Recognition and Management of Pediatric Dental Trauma and Infections 1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Dental emergencies are common during childhood and typically occur due to trauma or infection. The current evidence on managing dental injuries is from a dental perspective, with limited information on treating pediatric dental injuries in medical settings. Proper treatment of infection, correct storage, prompt repositioning, and replantation are essential for successful outcomes, as supported by the latest evidence-based guidelines. Pediatric patients have a better prognosis when proper treatment is provided without delay. Understanding potential issues enables providers to assess the severity of the condition, offer initial guidance and management, and recommend appropriate follow-up dental care. This continuing education activity aims to educate providers on how to care for children with low-acuity dental injuries and infections using an evidence-based approach. J pediatr Health Care. (2026) 40, 451-463. |
|
05/01/2026 to 06/30/2027 | $0.00 | $10.00 |
|
COVID-19 Considerations in High-risk Pediatric Populations 0.5 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members. |
|
04/16/2026 to 04/30/2027 | $0.00 | $0.00 |
|
I'm All Ears 0.75 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and non-members. |
|
02/18/2025 to 02/28/2027 | $0.00 | $0.00 |
|
Guidance for Implementing the AAP's 2023 Clinical Practice Guideline for the Evaluation and Treatment of Pediatric Obesity in Primary Care 1.00 NAPNAP Contact Hour. This course is an archived session from NAPNAP's Pediatric Virtual Symposium: 2024 Targeted Topics. The 2023 American Academy of Pediatrics (AAP) CPG for the Evaluation and Treatment of Obesity in Children and Adolescents recommends that children 2-18 years with overweight/obesity be comprehensively evaluated for comorbidities and offered multicomponent, family-based, Intensive Health Behavior and Lifestyle Treatment (IHBLT). This session will focus on the core components of IHBLT and the associated health outcomes. Additionally, participants will learn how to locate recognized Family Healthy Weight Programs and steps to take if there are no local programs. Led by a member of the AAP clinical practice guideline writing team and a member of the NAPNAP Childhood Obesity SIG, this session will help primary care providers assess and build their capacity around IHBLT. |
|
11/15/2024 to 11/30/2026 | $0.00 | $0.00 |
|
Leucovorin in Autism: An Evidence-Based and Clinically Informed Approach 1.25 NAPNAP Contact Hours of which 1.25 contains pharmacology content. This continuing education activity is offered free for NAPNAP Members and non-members. This presentation synthesizes the evidence on folinic acid in autism, with an emphasis on advances since 2018 within the context of foundational work. We will examine the pathophysiology of cerebral folate deficiency (CFD), clarify genetic contributors (e.g., FOLR1 and folate-pathway variants), and review clinical testing with folate receptor-α autoantibodies and related labs. Practical treatment guidance will cover formulation selection, dosing and titration, monitoring, adverse effects, and pharmacy/compounding and cost considerations. Taught by a clinician with extensive real-world experience, the presentation highlights where the evidence is strongest and how to implement it. Learners will finish with a concise, evidence-based framework for evaluating and managing CFD in autism within standard practice. |
|
11/12/2025 to 11/30/2027 | $0.00 | $0.00 |
|
RSV 2024-2025 – Is Your Pediatric Practice Ready? 1.0 NAPNAP Contact Hour of which 0.75 contain pharmacology content. This continuing education activity is free to National Association of Pediatric Nurse Practitioners (NAPNAP) members and non-members. This course will provide the necessary education enabling pediatric practice providers and staff to successfully prevent RSV in the most vulnerable pediatric populations using the recommendations to administer the appropriate RSV prevention to infants based on weight, age, pre-term birth history, presence of chronic conditions and race. |
|
10/10/2024 to 10/31/2026 | $0.00 | $0.00 |
|
Medically Complex Youth in Foster Care 1.0 NAPNAP Contact Hour. This continuing education activity is offered for free to NAPNAP Members until 1/31/2026. For non-members, this continuing education activity rate is $20. |
|
01/22/2025 to 01/31/2027 | $0.00 | $20.00 |
|
Influenza 2025-2026: Is Your Pediatric Practice Ready? 1.0 NAPNAP Contact Hour of which 0.75 contain pharmacology content. This continuing education activity is offered free for NAPNAP Members and non-members. As we enter influenza season, pediatric-focused APRNs can increase their knowledge and prepare to counsel families and restore confidence in influenza vaccines. This continuing education presentation will teach providers to balance communication of scientific data and vaccine efficacy with acknowledgment of parental concerns and fears, and help families feel empowered to make the best decisions when it comes to flu prevention. |
|
11/14/2025 to 11/30/2026 | $0.00 | $0.00 |
|
JPHC CE: Monitoring Vaccine Safety: United States Vaccine Safety Surveillance Systems 1.0 NAPNAP contact hour of which contain 1.0 pharmacology content. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Immunization is an effective public health tool to protect children from hospitalization and death from vaccine-preventable diseases. Vaccine safety monitoring is essential to understand risks of vaccination. The Centers for Disease Control and Prevention closely monitors vaccine safety through multiple surveillance systems, including V-safe, the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. This paper briefly discusses each surveillance system and available evidence that healthcare providers can use to respond to common vaccine concerns. As trusted sources of information about vaccines, pediatric nurses and nurse practitioners need to understand how vaccine safety is monitored, where to access reliable resources about vaccines, and when and where to report adverse events noted after vaccination. J Pediatr Health Care (2026) 40, Issue 1, P174-186. |
|
01/01/2026 to 02/28/2027 | $0.00 | $10.00 |